ANA provides Bangladesh with int’l transportation of Covid vaccines

Dhaka: All Nippon Airways (ANA), Japan's largest and five-star airline for eight consecutive years has partnered with the global transport and logistics provider Scan Global Logistics for the international transportation of Covid-19 vaccines manufactured in Japan to Bangladesh.
Besides, the airline also transports Covid-19 vaccines to Cambodia, Sri Lanka, Laos, East Timor, Fiji, and Maldives through the Japanese government's cooperation with the COVAX facility.
The COVAX Facilityblank is a logistical hub designed to maximise resource mobilisation and supply coordination led by Gavi, the global vaccine alliance leading COVAX efforts.
The initiative aims to secure equitable access to vaccines worldwide regardless of income levels and increasing availability in developing nations throughout Southeast Asia is key to this strategy.
By utilizing the COVAX facility, ANA is able to contribute to making Covid-19 vaccines swiftly available at an affordable price, leveraging economies of scale through guaranteeing purchase and market demand for vaccine.
The transportation of vaccines presents a number of logistical hurdles, requiring ANA to leverage its full range of expertise and experience gained at the forefront of cargo transportation.
Despite the challenges, ANA has an exceptional track record in the delivery of pharmaceutical goods and has established a reliable and efficient operational structure for the global delivery of vaccines and other crucial medical supplies.
In addition, ANA has been certified by IATA's Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) since 2017, making it the first Japanese airline to receive this distinction.
As part of its efforts to make flying safer, ANA has instituted the ANA Care Promiseblank, a comprehensive series of protocols designed to prevent the spread of Covid-19.
As the Covid-19 pandemic continues to affect nearly every aspect of life, ANA remains committed to doing all it can to empower healthcare workers and public health professionals worldwide.










